Blog Category: Consumer Protection

When patients pick up medication from the pharmacy, they are most likely asked, “Do you have any questions for the pharmacist?”, but are your patients aware of what pharmacists can help them with? Pharmacists are go-to experts on medication, knowledgeable about how medications work, what they treat, and how they interact with other products. Pharmacists […]

Read More ›

Almost 75% of Americans are clinically defined as overweight or obese, and over 11% have diabetes. America’s obsession with weight loss and dieting is well-documented, with a staggering $30 billion spent each year on diet products. Because of this, it is no surprise that drugs like semaglutide, liraglutide, and tirzepatide have “gone viral.” This class […]

Read More ›

What is Ketamine?  Finding information online about ketamine can be overwhelming, leaving a lot of patients and their families confused about its approved uses. Simply put, ketamine is an anesthetic with some hallucinogenic properties and is classified as a Schedule III non-narcotic substance under the federal  Controlled Substances Act. It can only be prescribed by […]

Read More ›

Medication errors cause avoidable harm in approximately 1 in 30 patients, with 25% of these patients experiencing severe or life-threatening harm. Aiming to prevent these errors, Drug Enforcement Administration. provided prescribers with the option to use e-prescriptions for controlled substances (CS) based on an interim final rule published in 2010. Since this rule became effective, […]

Read More ›

Injectable diabetes medications including semaglutide, namely Wegovy and Ozempic, have been in shortage since 2022, limiting patient access to the drug across the nation. Many other drugs have appeared on FDA’s shortage list in the past few years, including ADHD medications, chemotherapy treatments, and even antibiotics. However, the semaglutide shortage has been featured prominently in […]

Read More ›

Since the beginning of the COVID-19 pandemic, a disruption in access to opioid use disorder (OUD) treatment and recovery services, as well as increased social isolation and stress, contributed to a new surge of overdose deaths.  The emergence of illicit falsified prescriptions containing synthetic opioids, notably fentanyl, has contributed to this crisis.  Amid these continued […]

Read More ›

Young People and Substance Use Disorder  October is Youth Substance Use Prevention Month, highlighting prevention and treatment efforts to keep adolescents drug free. Although drug use has always been a concern for teens, there are specific challenges that today’s youth face. Thankfully, since the coronavirus disease 2019 (COVID-19), a National Institutes of Health survey has […]

Read More ›

The United States is home to one of the most secure drug supply chains in the world, but criminals still find pathways to buy and sell prescription drugs—including controlled substances—often using websites and social media platforms to do so. We compiled information from experts about how criminals use online platforms to sell these drugs illegally […]

Read More ›

Since early 2020, consumers have faced countless shortages and supply chain disruptions throughout the economy, from personal protective equipment to infant formula to cars. Prescription medications are not exempt. In recent months, hospitals and other health care facilities have struggled to obtain sufficient stock of even basic supplies, such as saline, and national media outlets […]

Read More ›

At any given time, between 30,000 and 40,000 illegal online pharmacies hawk substandard prescription drugs to unsuspecting patients. Law enforcement and government agencies have a steep hill to climb in stopping them, but “lock-and-suspend” shows promise. Our newest Rogue Rx Activity Report explores how locking and suspending the domain names of these sites directly impacts […]

Read More ›